US Patent Issued to Rutgers, The State University of New Jersey on March 17 for "GRP78-binding antibodies and use thereof in detecting or neutralizing GRP78" (New Jersey, New Mexico Inventors)

ALEXANDRIA, Va., March 17 -- United States Patent no. 12,577,301, issued on March 17, was assigned to Rutgers, The State University of New Jersey (New Brunswick, N.J.).

"GRP78-binding antibodies and use thereof in detecting or neutralizing GRP78" was invented by Renata Pasqualini (Newark, N.J.), Wadih Arap (Newark, N.J.), Fernanda I. Staquicini (Summit, N.J.), Fortunato Ferrara (Santa Fe, N.M.), Sara D'Angelo (Santa Fe, N.M.) and Andrew R.M. Bradbury (Santa Fe, N.M.).

According to the abstract* released by the U.S. Patent & Trademark Office: "Isolated or recombinant EphA5 or GRP78 targeting antibodies are provided. In some cases, antibodies of the embodiments can be used for the detection, diagnosis and/or therapeutic treatment of human d...